Correlation Between Oncotelic Therapeutics and Advanced Proteome

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncotelic Therapeutics and Advanced Proteome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncotelic Therapeutics and Advanced Proteome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncotelic Therapeutics and Advanced Proteome Therapeutics, you can compare the effects of market volatilities on Oncotelic Therapeutics and Advanced Proteome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncotelic Therapeutics with a short position of Advanced Proteome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncotelic Therapeutics and Advanced Proteome.

Diversification Opportunities for Oncotelic Therapeutics and Advanced Proteome

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Oncotelic and Advanced is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Oncotelic Therapeutics and Advanced Proteome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Advanced Proteome and Oncotelic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncotelic Therapeutics are associated (or correlated) with Advanced Proteome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Advanced Proteome has no effect on the direction of Oncotelic Therapeutics i.e., Oncotelic Therapeutics and Advanced Proteome go up and down completely randomly.

Pair Corralation between Oncotelic Therapeutics and Advanced Proteome

If you would invest  0.02  in Advanced Proteome Therapeutics on September 14, 2024 and sell it today you would earn a total of  0.00  from holding Advanced Proteome Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Oncotelic Therapeutics  vs.  Advanced Proteome Therapeutics

 Performance 
       Timeline  
Oncotelic Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncotelic Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Oncotelic Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Advanced Proteome 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Advanced Proteome Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Advanced Proteome is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Oncotelic Therapeutics and Advanced Proteome Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncotelic Therapeutics and Advanced Proteome

The main advantage of trading using opposite Oncotelic Therapeutics and Advanced Proteome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncotelic Therapeutics position performs unexpectedly, Advanced Proteome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Advanced Proteome will offset losses from the drop in Advanced Proteome's long position.
The idea behind Oncotelic Therapeutics and Advanced Proteome Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets